Home › Products › Oncology › Gemcite 1gm Injection
Gemcite 1gm Injection
Salt Composition: GEMCITABINE
- Manufacturer: ELI LILLY AND COMPANY INDIA PVT LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 1000MG
- Prescription Required
- Storage: Keep gemcite inj out of sight and reach of children. This medicine does not require any special storage conditions. Do not refrigerate or freeze.
₹5283.00₹5868.75
Inclusive of all taxes
Product Introduction
Gemcite 1gm Injection is a chemotherapy medication containing gemcitabine. It is indicated for the treatment of bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disease characterised by uncontrolled and abnormal cell multiplication. Inform your doctor if you have heart disease, liver disorders, kidney disorders, have recently undergone radiotherapy, or have been vaccinated before using Gemcite 1gm Injection. This injection is not recommended for children and adolescents under 18 years of age. Your doctor will monitor your blood cell counts and assess kidney and liver function at each administration. Use effective contraception during treatment and for at least six months after the final dose. This injection may affect fertility in male patients. Men receiving this medicine should not father a child during treatment and for 6 months following completion of treatment. Inform your doctor if you follow a salt-restricted diet, as Gemcite 1gm Injection contains sodium. Contact your doctor immediately if you experience shortness of breath, wheezing, changes in urine colour or volume, bleeding, or upper abdominal pain while taking Gemcite 1gm Injection.
Uses
The Gemcite 1gm injection uses include: To treat bladder cancer, in combination with cisplatin To treat ovarian cancer, in combination with carboplatin In the treatment of breast cancer, in combination with paclitaxel To treat pancreatic cancer In the treatment of Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin
How it works
Gemcite 1gm injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.
How to Use
Gemcite 1gm injection is administered as an intravenous infusion into the vein. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Gemcite 1gm Injection are: Pulmonary toxicity (shortness of breath, wheezing, cough) Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding) Pain or tenderness in the upper abdomen Allergic reactions, rashes, fever, swelling or sores in the mouth Common side effects of Gemcite 1gm Injection are: Nausea, vomiting Low blood cell count Loss of appetite Hair loss Swelling of ankles, feet, and fingers Insomnia Constipation, diarrhoea Headache Runny nose, chills Muscle pain, back pain Sweating hair loss liver problems blood in urine abnormal urine test Oedema (swelling of ankles, fingers, feet, face)
Expert Tips
It is not recommended to take Gemcite 1gm injection if you are allergic to Gemcitabine or any of its ingredients. During this treatment, your doctor may periodically monitor your complete blood counts, blood sugar, electrolytes, liver panel, and kidney parameters to prevent serious complications. This injection may impair fertility in male patients. Men taking this injection are advised not to father a child during the treatment and for 6 months after the treatment. Consult your doctor before starting this injection, and it is advised to get suggestions about fertility concerns from your doctor. It is advised for both men and women to follow proper contraceptive methods during and after the 6 months of the last dose.
References
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1700.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 870.
- Sun Pharmaceutical Industries, Electronic medicines compendium (emc), [ Revised on May 2022] [ Accessed on 20 Mar 2023], https://www.medicines.org.uk/emc/files/pil.7298.pdf
- Hospira, Inc, US Food and Drug Administration, [ Revised on June 2019 [ Accessed on 20 Mar 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020509s077lbl.pdf
Safety Advice
Pregnancy: unsafe Gemcite 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
Lungs: Consult your doctor Gemcite 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.
Breastfeeding: unsafe You must not breastfeed while being treated with Gemcite 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.